Effective June 30, 2024, after a career spanning more than 35 years, Kim R. Tsuchimoto, the Chief Financial Officer of Monopar Therapeutics Inc. (“Monopar” or the “Company”), will be retiring.
On May 23, 2024, the Company’s Board of Directors appointed, Karthik Radhakrishnan, age 53, to succeed Ms. Tsuchimoto as Monopar’s Chief Financial Officer, principal accounting officer and principal financial officer effective July 1, 2024.
As previously announced on April 15, 2024, Jeffrey R. Tarr, the former President and Chief Executive Officer of Skillsoft Corp. (the “Company”), retired from his position effective as of April 16, 2024 (the “Transition Date”).
The employment of Jason Dies as Interim Chief Executive Officer of Pitney Bowes Inc. (the “Company”) ended effective May 21, 2024.
Role change
Charles S. Cullum
Chief Financial Officer
SANDY SPRING BANCORP INC
Effective
2024-05-22
Filed
May 23, 2024, 7:59 PM ET
On May 22, 2024, the Board of Directors of Sandy Spring Bancorp, Inc. (the “Company”) appointed Charles S. Cullum, the Company’s current Deputy Chief Financial Officer and Treasurer, as Chief Financial Officer.
Departed
Philip J. Mantua
Chief Financial Officer
SANDY SPRING BANCORP INC
Successor
Charles S. Cullum
Filed
May 23, 2024, 7:59 PM ET
Philip J. Mantua, the Company’s current Chief Financial Officer, who previously announced his retirement, will continue with the Company until the end of the year to support this leadership transition.
On May 17, 2024, Kyle Udseth informed Pineapple Energy Inc. (the “Company”) of his decision to resign as Chief Executive Officer and as a director of the Company, effective May 17, 2024.
Departed
Jeffrey Rittichier
Chief Executive Officer
EMCORE CORP
Effective
2024-05-07
Filed
May 23, 2024, 7:59 PM ET
Effective on May 7, 2024 (the “Separation Date”), Jeffrey Rittichier departed as Chief Executive Officer and director of the Company.
the Company announced Mr. Baker’s retirement and that its Board of Directors (the “Board”) appointed Catherine “Cassie” J. Boggs to serve as Interim President and Chief Executive Officer.
On May 22, 2024, Phillips S. Baker, Jr., the President and Chief Executive Officer and a director of Hecla Mining Company (the “Company”), informed the Company that he retired from his officer position and resigned his director position effective immediately
Mr. Yendall will depart the Company on June 7, 2024 and will be entitled to the severance payments set forth under the applicable provisions of his employment agreement.
On May 23, 2024, SiriusPoint Ltd. (the “ Company ”) announced the appointment of James J. McKinney as its new Chief Financial Officer effective June 3, 2024, to replace Steve Yendall.
the Boards of NW Holdings and NW Natural designated Mr. Justin B. Palfreyman, President of NW Holdings and NW Natural, as successor to the office of CEO of NW Holdings and NW Natural, upon Mr. Anderson’s retirement.
David H. Anderson, Chief Executive Officer (CEO) of Northwest Natural Holding Company (NW Holdings) and Northwest Natural Gas Company (NW Natural) informed the Board at its May 23, 2024 meeting of his decision to retire from his position as CEO of NW Holdings and NW Natural effective April 1, 2025.
On May 17, 2024, Craig Snyder, the Chief Executive Officer and a member of the Board of Directors (the “Board”) of the Company, notified the Board that he will resign as Chief Executive Officer of the Company and as a member of the Board, effective as of May 27, 2024.
On May 23, 2024, the Board appointed Barbara Sher, the Company’s Chief Operating Officer, to the position of Chief Executive Officer, effective as of May 27, 2024.
Matthew Puckett will continue to serve as the Company’s Executive Vice President and Chief Financial Officer and principal financial officer until the Effective Date.
Appointed
Paul Vogel
Executive Vice President and Chief Financial Officer
On May 22, 2024, V. F. Corporation (the “Company”) announced the appointment of Paul Vogel as Executive Vice President and Chief Financial Officer and principal financial officer, effective as of July 8, 2024
Steven Van Dick informed Tenon Medical, Inc. (the “Company”) of his decision to retire and as a result, is resigning from his positions as Executive Vice President, Finance and Administration, Chief Financial Officer and Assistant Secretary effective as of July 31, 2024.
Departed
Robert W. Humphreys
Chief Executive Officer
DELTA APPAREL, INC
Effective
2024-06-29
Filed
May 22, 2024, 7:59 PM ET
Robert W. Humphreys submitted his resignation effective June 29, 2024, as Chairman of the Board and Chief Executive Officer along with all positions held by Mr. Humphreys with the Company
On May 22, 2024, Allient Inc. (the “Company”) announced the appointment of James A. Michaud as Senior Vice President and Chief Financial Officer of the Company, effective June 3, 2024.
On May 16, 2024, the Company and Jeffrey F. Eisenberg mutually agreed that Mr. Eisenberg would step down as the Chief Executive Officer of the Company, effective immediately
On May 16, 2024, the Board of Directors (the “Board”) of Xenetic Biosciences, Inc. (the “Company”) appointed James F. Parslow, the Company’s Chief Financial Officer, to the position of Interim Chief Executive Officer.
the Board of Directors (the “ Board ”) of The Children’s Place, Inc. (the “ Company ”) appointed Muhammad Umair, who is currently a Board member, as President and Interim Chief Executive Officer of the Company.
Mr. Umair succeeds Jane T. Elfers, who departed as President and Chief Executive Officer of the Company and as a member of the Board pursuant to a mutual agreement with the Company, effective as of the Effective Date.
Appointed
Deborah Knobelman
Chief Financial Officer and Chief Operations Officer
Kronos Bio, Inc.
Effective
2024-06-03
Filed
May 21, 2024, 7:59 PM ET
On May 20, 2024, the board of directors of Kronos Bio, Inc. (the “Company”) appointed Deborah Knobelman, Ph.D. as the Chief Financial Officer, principal financial officer and principal accounting officer of the Company, replacing Sandra Gardiner in such capacities, and as the Company’s Chief Operations Officer, with such appointments to be effective on June 3, 2024.
Departed
Sandra Gardiner
Chief Financial Officer
Kronos Bio, Inc.
Effective
2024-06-03
Successor
Deborah Knobelman
Filed
May 21, 2024, 7:59 PM ET
On May 20, 2024, the board of directors of Kronos Bio, Inc. (the “Company”) appointed Deborah Knobelman, Ph.D. as the Chief Financial Officer, principal financial officer and principal accounting officer of the Company, replacing Sandra Gardiner in such capacities, and as the Company’s Chief Operations Officer, with such appointments to be effective on June 3, 2024.
Appointed
Zack Ibrahim
Executive Vice President and Chief Financial Officer
On May 15, 2024, Broadway Financial Corporation (the “Company” or “Broadway”) (NASDAQ Capital Market: BYFC), the holding company of City First Bank, National Association (the “Bank” and collectively with the Company, “City First Broadway”), appointed Zack Ibrahim, age 48, as Executive Vice President and Chief Financial Officer (“CFO”) of the Company and the Bank.
On April 8, 2024, the Board of Directors (the "Board") of SolarWindow Technologies, Inc. (the “Company”) appointed Amit Singh (also known as Amit Singh Dang) as the Company's President and Chief Executive Officer (“CEO”), effective May 1, 2024
appointed Michael J. Donfris, 60, to serve as the Company’s Senior Vice President, Finance, effective as of June 17, 2024, and to then serve as the Company’s Senior Vice President, Chief Financial Officer (principal financial officer), effective as of the day immediately following the filing of the Company’s Quarterly Report on Form 10-Q for the quarter ended May 31, 2024
Lorie L. Tekorius, the Company’s Chief Executive Officer and President, will cease serving as the Company’s principal financial officer at the end of the day on the date of filing such Form 10-Q.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.